ShiraTronics, Inc., a Brooklyn Park, Minnesota-based private medical device company, completed an additional Series A financing of $3m.
This brought the Series A financing to a total of $36m.
The financing was provided by Breakout Ventures (BOV). BOV joins previous Series A lead investors USVP, Amzak Health, and Strategic HealthCare Investment Partners (S.H.I.P), with participation from Aperture Ventures, LivaNova PLC, and an Academic Institution.
The company intends to use the funds to further accelerate its path to market.
Led by President and Chief Executive Officer Lynn Elliott, and Mudit K. Jain, PhD, a co-founder and Chairman of the Board, ShiraTronics provides an innovative therapy for migraine headaches. The company, focused on developing and clinically testing its neuromodulation technology, was spun off from NuXcel, an electrical medical device focused accelerator.